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NADH:ubiquinone oxidoreductase or complex I is a major con-
tributor to ATP generation in mitochondria. It is also a source of
detrimental free radicals as well as a target for oxidative damage
by them. An unusual feature of complex I from several species is
the active/de-active (A/D) transition [1,2]. The A-form catalyses
the rapid physiological reaction of NADH oxidation and sponta-
neously converts to the dormant D-form within minutes if the
enzyme is idle (e.g. during ischaemia). The D-form can undergo
re-activation during slow catalytic turnover(s). Cys-39 of the
mitochondrially-encoded subunit ND3 becomes exposed upon de-
activation [2]. The A/D transition plays an important role in tissue
response to hypoxia, therefore deactivation of the enzyme is one
of the key mitochondrial events during ischaemia. The mechanism
of deactivation is currently unknown, but we identiﬁed two new
subunits involved in a conformational change during the A/D
transition: ND1 and 39 kDa (NDUFA9) [2]. Most likely, de-
activation is a result of concerted structural rearrangement of
several subunits located in the region of the quinone binding site
which leads to disruption of the terminal electron transfer. We
suggested a physiological role of maintaining the enzyme in the
D-form during the ischaemic period. Accumulation of the D-form
could decrease the initial burst of respiration followed by ROS
formation after reoxygenation. Thus, the A/D transition could be
an intrinsic mechanism for decreasing oxidative damage during
an early phase of reoxygenation. However, Cys-39 of the ND3
subunit, exposed in the D-form, is susceptible to modiﬁcation by
ROS and nitric oxide metabolites. Modiﬁcation arrests re-activa-
tion of the D-form and inhibits the enzyme. The nature of thiol
modiﬁcation deﬁnes reversibility, re-activation dynamics, effect
on mitochondrial ATP-production and therefore, outcome follow-
ing ischaemia–reperfusion injury. Modulation of the A/D equilib-
rium of complex I in situ could ameliorate ischaemia/reperfusion
damage. Progress towards further characterisation will be
accessed and regulatory implications of the A/D transition in situ
discussed.
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Mitochondrial Complex I is a target of pathogenicmutations because
seven of its subunits are encoded in mtDNA. Modeling of mtDNA
mutations in bacteria offers a reasonably stable platform for experi-
mentation. Therefore we tested mutations by means of modeling them
in Escherichia coli NDH-1, the bacterial counterpart of mitochondrial
Complex I. A knockout E. coli NUO subunit strain was produced and
complemented in-trans with an expression plasmid containing the
wild-type or mutated gene. Deamino-NADH oxidation and membrane
energization were monitored simultaneously by spectrophotometry
using Neutral Red as a probe in inverted membrane vesicles. This
allowed the determination of proton pump stoichiometry and mem-
brane leak parameters by means of curve ﬁtting with numerical
integration of a model equation throughout the d-NADH oxidation
pulse. Mutation in E24 of the human ND1 subunit causes an LHON/
MELAS overlap syndrome. The E. coli counterpart of ND1-E24 is NUOH-
E36. Its elimination caused a 95% inhibition of d-NADH oxidation and
zeroed the proton pumping. An E36D replacement approximately
halved the d-NADH oxidation rate and the proton pumping stoichiom-
etry. Elimination ofNUOH-E157 in a transmembrane helix halved the d-
NADHoxidation capacity but it did not affect proton pumping, although
the T. thermophilus homolog NQO8-E163 has been suggested to be
involved in proton translocation. ND6 is a hotspot of mtDNAmutations.
M64, Y59 and A72 are sites of pathogenic mutations and were studied
in E. coliNUOJ for effects on proton pumping. Mutations in all three sites
resulted in marked decrease in d-NADH oxidation in E. coli. The most
effective mutations affecting proton pumping were the Y59F mutation
and the elimination of M72, which actually is a counterpart of the
human A72. The ND4L/NUOK subunit contains two highly conserved
glutamates in the middle of transmembrane helices. Elimination of
these carboxylic moieties killed the enzyme. Putting the twin carboxyls
to a single helix by replacing E72 with Q72 and I39 with D39 halved
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the d-NADHoxidation capacity but did not affect proton pumping. If the
one-turn shifted carboxyl was in another helix than the remaining one,
the enzyme was inactive. Regression showed a threshold behavior,
when the proton pumping of the mutants was plotted against d-NADH
oxidation. The relation between proton pumping and redox reaction is
not linear suggesting that this glutamate pair is involved in proton
pumping.
doi:10.1016/j.bbabio.2014.05.045
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With a mass of almost 1 MDa complex I is the largest enzyme of
the mitochondrial respiratory chain. Complex I dysfunction is known
to cause human disease often involving myopathy and neurodegen-
eration. We have analyzed the complete enzyme from the strictly
aerobic yeast Yarrowia lipolytica by X-ray crystallography and
electron microscopy [1,2]. The arrangement of functional modules
offers clues to understand redox-linked proton translocation by
complex I. In addition to the 14 central subunits that are conserved
throughout and represent the minimal form of the enzyme,
mitochondrial complex I comprises some 30 so-called accessory
subunits [3]. We showed that accessory subunit NB4M (human
ortholog NDUFA6, LYR motif containing protein 6), a member of the
LYRM family of proteins, anchors an acyl carrier protein to the
ubiquinone reduction module of complex I and is essential for
catalytic activity [4].
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The aim of this study was to immobilize Complex I in a bio-
mimetic environment on a gold layer deposited on an ATR-crystal
in order to functionally probe the enzyme against substrates and
inhibitors via Surface-Enhanced IR Absorption Spectroscopy
(SEIRAS) and Cyclic Voltammetry (CV). To achieve this immobi-
lization, two methods were probed, both based on the creation of
a high afﬁnity Self-Assembled Monolayer (SAM): the ﬁrst made
use of the afﬁnity of Ni-NTA towards a hexahistidine tag that was
genetically engineered into Complex I for puriﬁcation purposes;
the second exploited the afﬁnity of the enzyme towards its
natural substrate, NADH. Both approaches have been found to be
successful despite the different distance and orientation towards
the electrode. Furthermore the effect of the incorporation in a
lipid bilayer was probed.
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Complex I (NADH–ubiquinone oxidoreductase) in the respiratory
chains of mitochondria and bacteria catalyzes the transfer of
electrons from NADH to ubiquinone (UQ), and couples the free
energy of the reaction to proton pumping across the membrane. The
established proton electrochemical gradient is then used to drive the
synthesis of ATP — the energy currency of the cell. Site-directed
mutagenesis, kinetic experiments as well as equilibrium redox
titrations have shown that the UQ reduction reaction is linked with
the proton pumping through a long-range indirect coupling
mechanism. Some of the key elements involved in long-range
coupling have indeed been identiﬁed in the recently solved crystal
structure of the entire complex I from the thermophilic bacterium
Thermus thermophilus. However, despite these advances the molec-
ular level description of the proton pumping mechanism of complex
I has remained elusive. Here, with the help of state-of-the-art
classical molecular dynamics (MD) simulations performed on the
entire crystal structure of complex I immersed in a lipid-solvent
environment, we present molecular level insights to the coupling
between UQ reduction and proton pumping. The data from
simulations performed in different redox and protonation states
suggest that the coupling involves both long-range conformational
transitions and electrostatic effects.
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